COL11A1 and adrenal cortex carcinoma: Having established that Wnt/β-catenin activity and COL11A1 expression were correlated with poor outcomes in patients, we next wanted to evaluate the effects of Wnt/β-catenin inhibition on the ECM gene signature and investigate the utility of inhibition as a therapeutic strategy in ACC.